Medications

FDA approves Litfulo for teens, adults with alopecia areata

The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.

Health

Los Angeles county's growing youth firearm crisis

The majority of pediatric firearm injuries in Los Angeles County occur in neighborhoods with limited social, health and educational opportunity, according to a new study exploring incidents from 2010 to 2021. The research ...

page 4 from 14